These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 35138828)
1. Synthetic Conjugated Oligoelectrolytes Are Effective siRNA Transfection Carriers: Relevance to Pancreatic Cancer Gene Therapy. Yang C; Huang H; Singh NM; Zhou C; Yang G; Xu Z; Lin H; Xu G; Yong KT; Bazan GC Biomacromolecules; 2022 Mar; 23(3):1259-1268. PubMed ID: 35138828 [TBL] [Abstract][Full Text] [Related]
2. Assembling Mn:ZnSe quantum dots-siRNA nanoplexes for gene silencing in tumor cells. Wang Y; Yang C; Hu R; Toh HT; Liu X; Lin G; Yin F; Yoon HS; Yong KT Biomater Sci; 2015 Jan; 3(1):192-202. PubMed ID: 26214202 [TBL] [Abstract][Full Text] [Related]
3. Biodegradable nanocapsules as siRNA carriers for mutant K-Ras gene silencing of human pancreatic carcinoma cells. Lin G; Hu R; Law WC; Chen CK; Wang Y; Li Chin H; Nguyen QT; Lai CK; Yoon HS; Wang X; Xu G; Ye L; Cheng C; Yong KT Small; 2013 Aug; 9(16):2757-63. PubMed ID: 23427041 [TBL] [Abstract][Full Text] [Related]
4. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles. Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377 [TBL] [Abstract][Full Text] [Related]
5. RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicles. Panwar N; Yang C; Yin F; Yoon HS; Chuan TS; Yong KT Nanotechnology; 2015 Sep; 26(36):365101. PubMed ID: 26291710 [TBL] [Abstract][Full Text] [Related]
6. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
7. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand. Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765 [TBL] [Abstract][Full Text] [Related]
9. The development of ternary nanoplexes for efficient small interfering RNA delivery. Şalva E; Turan SÖ; Akbuğa J Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377 [TBL] [Abstract][Full Text] [Related]
10. Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1. Chen LM; Le HY; Qin RY; Kumar M; Du ZY; Xia RJ; Deng J World J Gastroenterol; 2005 Feb; 11(6):831-8. PubMed ID: 15682475 [TBL] [Abstract][Full Text] [Related]
11. Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo. Zhu H; Liang ZY; Ren XY; Liu TH Cancer Biol Ther; 2006 Dec; 5(12):1693-8. PubMed ID: 17106254 [TBL] [Abstract][Full Text] [Related]
12. A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiency. Tagalakis AD; Castellaro S; Zhou H; Bienemann A; Munye MM; McCarthy D; White EA; Hart SL Int J Nanomedicine; 2015; 10():2673-83. PubMed ID: 25878500 [TBL] [Abstract][Full Text] [Related]
14. Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette. Wang W; Wang CY; Dong JH; Chen X; Zhang M; Zhao G World J Gastroenterol; 2005 Apr; 11(13):2026-31. PubMed ID: 15801000 [TBL] [Abstract][Full Text] [Related]
15. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer]. Liu JP; Yuan SZ; Zhang SN Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254 [TBL] [Abstract][Full Text] [Related]
16. Carbon Dioxide-Derived Biodegradable and Cationic Polycarbonates as a New siRNA Carrier for Gene Therapy in Pancreatic Cancer. Zhang X; Lin ZI; Yang J; Liu GL; Hu Z; Huang H; Li X; Liu Q; Ma M; Xu Z; Xu G; Yong KT; Tsai WC; Tsai TH; Ko BT; Chen CK; Yang C Nanomaterials (Basel); 2021 Sep; 11(9):. PubMed ID: 34578632 [TBL] [Abstract][Full Text] [Related]
17. Bioreducible, arginine-rich polydisulfide-based siRNA nanocomplexes with excellent tumor penetration for efficient gene silencing. Zhang X; Hong K; Sun Q; Zhu Y; Du J Biomater Sci; 2021 Jul; 9(15):5275-5292. PubMed ID: 34180478 [TBL] [Abstract][Full Text] [Related]
18. Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes. Chen Z; Zhang T; Wu B; Zhang X Int J Nanomedicine; 2016; 11():991-1002. PubMed ID: 27042054 [TBL] [Abstract][Full Text] [Related]
19. The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells. Zhong Y; Xia Z; Liu J; Lin Y; Zan H Oncol Rep; 2012 Apr; 27(4):1003-10. PubMed ID: 22200969 [TBL] [Abstract][Full Text] [Related]
20. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells. Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]